Form D · Other Health Care
TMRW Life Sciences, Inc.
New York, NY · CIK 0001759388
Offering snapshot reported Apr 24, 2026 · SEC filing
- Reported sold
- $38.4M Offering amount: $38.4M
- Investors reported
- 59 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 26, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2026 | Initial | $38,358,904 | No comparison | 59 | SEC filing |
| Jul 12, 2024 | Initial | $28,172,940 | No comparison | 69 | SEC filing |
| May 13, 2022 | Amendment | $100,155,975 | $19,917,780vs Jul 15, 2021 | 59 | SEC filing |
| Jul 15, 2021 | Initial | $80,238,195 | No comparison | Not reported | SEC filing |
| Feb 12, 2021 | Initial | $20,000,000 | No comparison | 35 | SEC filing |
| May 19, 2020 | Amendment | $36,500,000 | $7,500,000vs Dec 23, 2019 | 34 | SEC filing |
| Dec 23, 2019 | Initial | $29,000,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581848
Source: Form D, filed Apr 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Abram | Director |
| Tara Comonte | Director, Executive |
| Emily Drabant Conley | Director |
| Emily Drabant Conley | Director |
| Greg Eisner | Director |
| Melanie Goldey | Executive |
| Alan Murray | Director |
| Roberta Myers | Director |
| Jeffrey Port | Director |
| William Schoolcraft | Director |
| Andrew Schwab | Director |
| Vinay Shah | Director |
| Louis Villaba | Director |
| Louis Villalba | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
250 Hudson Street Suite 102
New York, NY, 10013
New York, NY, 10013